LAMPROPOULOS FRED P 4

Accession 0001415889-25-006309

CIK 0000856982other

View on SEC.gov Company Profile

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 8:23 PM ET

Size

29.2 KB

Accession

0001415889-25-006309

Insider Transaction Report

Form 4

Period: 2025-02-27

MERIT MEDICAL SYSTEMS INCMMSI

LAMPROPOULOS FRED P

DirectorPresident & CEO

Transactions

Tax PaymentSwap
Common Stock, No Par Value
2025-02-28$102.04/sh−26,043$2,657,428→ 1,117,348 total
Tax PaymentSwap
Common Stock, No Par Value
2025-02-28$102.04/sh−2,494$254,488→ 10,734 total(indirect: By Spouse)
Tax Payment
Common Stock, No Par Value
2025-02-27$98.50/sh−13,501$1,329,849→ 1,085,005 total
Exercise/ConversionSwap
Common Stock, No Par Value
2025-02-28$44.80/sh+38,002$1,702,490→ 1,143,391 total
Exercise/ConversionSwap
Common Stock, No Par Value
2025-02-28$44.80/sh+4,000$179,200→ 13,228 total(indirect: By Spouse)
Award
Common Stock, No Par Value
2025-02-27+30,755→ 1,098,506 total
Award
Common Stock, No Par Value
2025-02-28+20,384→ 1,105,389 total
Exercise/ConversionSwap
Non-qualified stock options (right to buy)
2025-02-28−38,002→ 0 total
Exercise: $44.80From: 2019-03-02Exp: 2025-03-02→ Common Stock (38,002 underlying)
Exercise/ConversionSwap
Non-qualified stock options (right to buy)
2025-02-28−4,000→ 0 total(indirect: By Spouse)
Exercise: $44.80From: 2019-03-02Exp: 2025-03-02→ Common Stock (4,000 underlying)

Holdings

Non-qualified stock options (right to buy)
Exercise: $56.25From: 2022-03-19Exp: 2028-03-19→ Common Stock (58,083 underlying)
58,083
Non-qualified stock options (right to buy)
(indirect: By Spouse)
Exercise: $55.73From: 2020-03-01Exp: 2026-03-01→ Common Stock (2,000 underlying)
2,000
Non-qualified stock options (right to buy)
Exercise: $37.71From: 2021-02-26Exp: 2027-02-26→ Common Stock (100,334 underlying)
100,334
Common Stock, No Par Value
(indirect: By 401(k))
97,798
Common Stock, No Par Value
(indirect: By Spouse)
90
Non-qualified stock options (right to buy)
Exercise: $55.73From: 2020-03-01Exp: 2026-03-01→ Common Stock (159,151 underlying)
159,151
Non-qualified stock options (right to buy)
Exercise: $70.58From: 2024-02-28Exp: 2030-02-28→ Common Stock (54,302 underlying)
54,302

Footnotes (14)

[F1]Represents plan holdings as of 02.28.2025.
[F10]Becomes exercisable in equal annual installments of 20% commencing 3/1/2020.
[F11]Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 3/1/2020. Options not vested as of 6/22/2020 have been forfeited.
[F12]Becomes exercisable in equal annual installments of 25% commencing 2/26/2021.
[F13]Becomes exercisable in equal annual installments of 25% commencing 03/19/2022.
[F14]Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.
[F2]Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse.
[F3]These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02/28/2022.
[F4]The Reporting Person surrendered 13,051 shares of common stock to the Issuer for payroll taxes. No shares were sold in the open market.
[F5]Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.
[F6]The Reporting Person surrendered 26,043 shares of common stock to the Issuer for payroll taxes and payment of the option price. No shares were sold in the open market.
[F7]The Reporting Person's spouse surrendered 2,494 shares of common stock to the Issuer for payroll taxes and payment of the option price. No shares were sold in the open market.
[F8]Becomes exercisable in equal annual installments of 20% commencing 3/2/2019.
[F9]Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 3/2/2019. Options not vested as of 6/22/2020 have been forfeited.

Documents

1 file

4
form4-03042025_010339.xmlPrimary

Issuer

MERIT MEDICAL SYSTEMS INC

CIK 0000856982

→

Entity typeother

Related Parties

filerCIK 0000901534

Filing Metadata

Form type: 4
Filed: Mar 2, 7:00 PM ET
Accepted: Mar 3, 8:23 PM ET
Size: 29.2 KB

View on SEC.gov